PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)

Media coverage

• Title	PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
  Media name/outlet	Drug Genius
  Country	United States
  Date	20/9/12
  URL	ct.moreover.com/?a=43060596422&p=1gw&v=1&x=TNR294rBesGHXtZHwkANWA
  Persons	Junyong Park

• Title	PegIFN Alfa-2a and RBV for 16 or 24 Weeks in Patients With Chronic Hepatitis C(CHC) 2 With Rapid Virologic Response(RVR)
  Media name/outlet	Clinical Trials.gov
  Country	United States
  Date	18/10/2
  Persons	Junyong Park